Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
29
30
Next >
Hopeful Golden Cross Forms On Regeneron Pharmaceuticals's Chart
October 03, 2022
Tickers
REGN
Tags
REGN
Movers
Benzinga
From
Benzinga
Analyst Ratings for Regeneron Pharmaceuticals
October 03, 2022
Tickers
REGN
Tags
BZI/AAR
Analyst Ratings
REGN
From
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
Tickers
ABBV
APLS
AXSM
BIIB
Tags
UNH
MCK
Benzinga
From
Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
Tickers
REGN
SNY
Tags
Market News
SNY
Large Cap
From
Benzinga
Ocular Therapeutix's Wet AMD Candidate Shows Sustained, Comparable Clinical Activity Vs. Eylea
September 27, 2022
Tickers
OCUL
REGN
Tags
Trading Ideas
Penny Stocks
Health Care
From
Benzinga
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
Tickers
AMGN
ASRT
BRK-A
BRK-B
Tags
AMGN
MRNA
GILD
From
InvestorPlace
The Top 5 Stocks Cathie Wood Is Buying This Week
September 23, 2022
Tickers
ADBE
ARKG
ARKK
ARKW
Tags
REGN
Today's Market
PRNT
From
InvestorPlace
$100 Invested In This Stock 10 Years Ago Would Be Worth $500 Today
September 20, 2022
Tickers
REGN
Tags
BZI/POD
Dividends
Market News
From
Benzinga
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
Benzinga
REGN
From
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
Tickers
BMY
PFE
REGN
SNY
Tags
BMY
Market News
REGN
From
Motley Fool
WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete
September 16, 2022
Tickers
GSK
REGN
RHHBF
RHHBY
Tags
Market News
VIR
RHHBY
From
Benzinga
Intellia Therapeutics Posts Back To Back Positive Data From Gene Editing Therapies
September 16, 2022
Tickers
NTLA
REGN
Tags
Market News
News
NTLA
From
Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Tickers
ALNY
CADL
CLSN
EW
Tags
REGN
PFE
Biotech Catalysts / EOD Summary
From
Benzinga
Alnylam/Regeneron-Backed NASH Candidate Shows Encouraging Safety Profile In Healthy Volunteers
September 15, 2022
Tickers
ALNY
REGN
Tags
News
REGN
Briefs
From
Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Tickers
ABBV
AMGN
BMY
GH
Tags
News
AMGN
LLY
From
Benzinga
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
September 14, 2022
Tickers
ASLN
REGN
SNY
Tags
Market News
General
Penny Stocks
From
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
Tickers
ABBV
AMGN
BMY
GH
Tags
BMY
Market News
GILD
From
Benzinga
A Major October Catalyst Could Make This Eye Stock A Ten Bagger, Analyst Says
September 13, 2022
Tickers
NVS
OTLK
REGN
RHHBY
Tags
Trading Ideas
Penny Stocks
Health Care
From
Benzinga
Regeneron's Bispecific Antibodies Show Encouraging Anti Tumor Activity
September 12, 2022
Tickers
REGN
Tags
REGN
News
Large Cap
From
Benzinga
9 Analysts Have This to Say About Regeneron Pharmaceuticals
September 09, 2022
Tickers
REGN
Tags
Analyst Ratings
REGN
BZI/AAR
From
Benzinga
Analyst Ratings for Regeneron Pharmaceuticals
September 09, 2022
Tickers
REGN
Tags
Analyst Ratings
REGN
BZI/AAR
From
Benzinga
Jefferies Upgrades Regeneron Pharmaceuticals: Here's What You Need To Know
September 09, 2022
Tickers
REGN
Tags
Analyst Ratings
REGN
Benzinga
From
Benzinga
'Highly Compelling' Eye Drug Data Has Wall Street Stampeding To Buy This 'Large Cap Growth Story.' Even After $15B In Market Cap Was Added
September 09, 2022
Tickers
REGN
Tags
Price Target
Briefs
REGN
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
Tickers
ADCT
ALEC
ANNX
ARVN
Tags
LINC
SHLS
Upgrades
From
Benzinga
What 9 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
September 09, 2022
Tickers
REGN
Tags
BZI/AAR
Analyst Ratings
REGN
From
Benzinga
Regeneron Pharmaceuticals To $851? Here Are 5 Other Price Target Changes For Friday
September 09, 2022
Tickers
ALGN
AXL
LOVE
NAVI
Tags
Price Target Changes
Market News
Markets
From
Benzinga
US Stock Futures Surge; Fed Speakers In Focus
September 09, 2022
Tickers
ABM
KR
REGN
RH
Tags
Small Cap
A Peek Into The Markets
REGN
From
Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
September 09, 2022
Tickers
AEO
AGS
AKA
ALBO
Tags
EVEX
Trading Ideas
LYFT
From
Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Tickers
ALNY
AMYT
AXSM
LLY
Tags
LLY
AXSM
SINT
From
Benzinga
Why Regeneron Pharmaceuticals Stock Is Crushing It Today
September 08, 2022
Tickers
BAYN
REGN
RHHBY
Tags
Recent Press Releases
BAYN
Market News
From
Motley Fool
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.